These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27009263)

  • 1. Protein biomarkers discriminate Leishmania major-infected and non-infected individuals in areas endemic for cutaneous leishmaniasis.
    Kammoun-Rebai W; Naouar I; Libri V; Albert M; Louzir H; Meddeb-Garnaoui A; Duffy D
    BMC Infect Dis; 2016 Mar; 16():138. PubMed ID: 27009263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia.
    Sassi A; Louzir H; Ben Salah A; Mokni M; Ben Osman A; Dellagi K
    Clin Exp Immunol; 1999 Apr; 116(1):127-32. PubMed ID: 10209516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cellular and humoral immune responses to Phlebotomus papatasi salivary gland antigens in endemic areas differing in prevalence of Leishmania major infection.
    Kammoun-Rebai W; Bahi-Jaber N; Naouar I; Toumi A; Ben Salah A; Louzir H; Meddeb-Garnaoui A
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005905. PubMed ID: 29023574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Concordance of leishmaniasis cutaneous tests in Tunisia].
    Ben Alaya Bouafif N; Ben Salah A; Louzir H; Zaâtour A; Bel Haj Hamida N; Mighri F; Gharbi A; Gramiccia M; Gradoni L; Dellagi K; Ben Ismaïl R
    Arch Inst Pasteur Tunis; 2001; 78(1-4):11-6. PubMed ID: 14658234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity Against
    Boussoffara T; Chelif S; Ben Ahmed M; Mokni M; Ben Salah A; Dellagi K; Louzir H
    Front Cell Infect Microbiol; 2018; 8():397. PubMed ID: 30483482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reappraisal of Leishmanin Skin Test (LST) in the management of American Cutaneous Leishmaniasis: A retrospective analysis from a reference center in Argentina.
    Krolewiecki AJ; Almazan MC; Quipildor M; Juarez M; Gil JF; Espinosa M; Canabire M; Cajal SP
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005980. PubMed ID: 28981507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity to L. major.
    Kemp M; Handman E; Kemp K; Ismail A; Mustafa MD; Kordofani AY; Bendtzen K; Kharazmi A; Theander TG
    FEMS Immunol Med Microbiol; 1998 Mar; 20(3):209-18. PubMed ID: 9566492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to heterologous leishmanins in cutaneous leishmaniasis in Nigeria--discovery of a new focus.
    Agwale SM; Duhlinska DD; Grimaldi Júnior G
    Mem Inst Oswaldo Cruz; 1998; 93(1):23-7. PubMed ID: 9698838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surrogate markers of immunity to Leishmania major in leishmanin skin test negative individuals from an endemic area re-visited.
    Nylén S; Khamesipour A; Mohammadi A; Jafari-Shakib R; Eidsmo L; Noazin S; Modabber F; Akuffo H
    Vaccine; 2006 Nov; 24(47-48):6944-54. PubMed ID: 17049693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania major large RAB GTPase is highly immunogenic in individuals immune to cutaneous and visceral leishmaniasis.
    Chamakh-Ayari R; Chenik M; Chakroun AS; Bahi-Jaber N; Aoun K; Meddeb-Garnaoui A
    Parasit Vectors; 2017 Apr; 10(1):185. PubMed ID: 28416006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response to Leishmania antigen in anthroponotic cutaneous leishmaniasis.
    Ajdary S; Riazi-Rad F; Alimohammadian MH; Pakzad SR
    J Infect; 2009 Aug; 59(2):139-43. PubMed ID: 19560211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXP3 expression and frequency of regulatory T cells in healed individuals from Leishmania major infection and the asymptomatic cases.
    Bahrami F; Darabi H; Riazi-Rad F; Khaze V; Ajdary S; Alimohammadian MH
    Hum Immunol; 2014 Oct; 75(10):1026-33. PubMed ID: 25167770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive validity of naturally acquired delayed-type hypersensitivity to leishmanin in resistance to Leishmania major-associated cutaneous leishmaniasis.
    Ben Salah A; Louzir H; Chlif S; Mokni M; Zaatour A; Raouene M; Ismail RB; Dellagi K
    J Infect Dis; 2005 Dec; 192(11):1981-7. PubMed ID: 16267771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.
    Bottrel RL; Dutra WO; Martins FA; Gontijo B; Carvalho E; Barral-Netto M; Barral A; Almeida RP; Mayrink W; Locksley R; Gollob KJ
    Infect Immun; 2001 May; 69(5):3232-9. PubMed ID: 11292745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reevaluating leishmanin skin test as a marker for immunity against cutaneous leishmaniasis.
    Momeni Boroujeni A; Aminjavaheri M; Moshtaghian B; Momeni A; Momeni AZ
    Int J Dermatol; 2013 Jul; 52(7):827-30. PubMed ID: 23621513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dichotomy of protective cellular immune responses to human visceral leishmaniasis.
    Khalil EA; Ayed NB; Musa AM; Ibrahim ME; Mukhtar MM; Zijlstra EE; Elhassan IM; Smith PG; Kieny PM; Ghalib HW; Zicker F; Modabber F; Elhassan AM
    Clin Exp Immunol; 2005 May; 140(2):349-53. PubMed ID: 15807861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of IL-12RB1, IL-12B, CXCR-3 and IL-17a expression in cases affected by a non-healing form of cutaneous leishmaniasis: an observational study design.
    Moafi M; Rezvan H; Sherkat R; Taleban R; Asilian A; Zarkesh Esfahani SH; Nilforoushzadeh MA; Jaffary F; Feizi A
    BMJ Open; 2017 Jan; 7(1):e013006. PubMed ID: 28132002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of leishmanin skin test and its relationship with the clinical form and duration of cutaneous leishmaniasis.
    Sadeghian G; Momeni A; Siadat AH; Yousefi P
    Dermatol Online J; 2006 Dec; 12(7):3. PubMed ID: 17459289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for Leishmania asymptomatic infection in endemic foci of cutaneous leishmaniasis in Venezuela: a combination of leishmanin skin test and PCR using blood clots improves detection and enables identification of species.
    Torrellas A; Ferrer E; Cruz I; De Lima H; Borges R; Delgado O; Moffi P; Miles MA; Feliciangeli MD
    Trans R Soc Trop Med Hyg; 2020 Jun; 114(6):433-439. PubMed ID: 31974548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.